{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:01:27Z","timestamp":1784574087190,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"DOI":"10.1007\/s13730-026-01164-9","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T05:41:07Z","timestamp":1784526067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Histopathological improvement in kidney AL amyloid deposits following daratumumab-based chemotherapy and autologous peripheral blood stem cell transplantation: a case report"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-0465","authenticated-orcid":false,"given":"Shuma","family":"Hirashio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Ohnari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moe","family":"Kadono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiro","family":"Tachiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"issue":"1","key":"1164_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1001\/jama.2020.5493","volume":"324","author":"MA Gertz","year":"2020","unstructured":"Gertz MA, Dispenzieri A. Systemic amyloidosis recognition, prognosis, and therapy: a systematic review. JAMA. 2020;324(1):79\u201389.","journal-title":"JAMA"},{"issue":"1","key":"1164_CR2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ndt\/gfae224","volume":"40","author":"S Anand","year":"2024","unstructured":"Anand S, O\u2019Neill-Dee M, Sanchorawala V, Verma A. Light-chain (AL) amyloidosis for nephrologists \u2013 treatment standard. Nephrol Dial Transplant. 2024;40(1):34\u201347.","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"1164_CR3","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","volume":"2","author":"TP Quock","year":"2018","unstructured":"Quock TP, Yan T, Chang E, Guthrie S, Broder MS. Epidemiology of AL amyloidosis: a real-world study using US claims data. Blood Adv. 2018;2(10):1046\u201353.","journal-title":"Blood Adv"},{"issue":"1","key":"1164_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18990-3","volume":"12","author":"HA Hou","year":"2022","unstructured":"Hou HA, Tang CH, Goh CH, Shen SP, Huang KC, Qiu H, et al. A population-based cohort study of the epidemiology of light-chain amyloidosis in Taiwan. Sci Rep. 2022;12(1):15736.","journal-title":"Sci Rep"},{"issue":"1","key":"1164_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-025-04136-w","volume":"26","author":"HJ Vasstrand","year":"2025","unstructured":"Vasstrand HJ, Raki M, Skrunes R, Leh S, Thomsen J, Gudmundsdottir H, et al. Epidemiology and clinical presentation of kidney amyloidosis have changed over the past three decades: a nationwide population-based study. BMC Nephrol. 2025;26(1):272.","journal-title":"BMC Nephrol"},{"key":"1164_CR6","doi-asserted-by":"crossref","unstructured":"Chowdhury R, Shah S, Latcha S, Lobato L. Kidney disease in systemic amyloidosis: a review of amyloid, amyloid serum A protein, leukocyte chemotactic factor 2, and transthyretin amyloid. Kidney360. 2024;5(12):1925\u201337.","DOI":"10.34067\/KID.0000000600"},{"issue":"1","key":"1164_CR7","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13506129.2019.1672650","volume":"27","author":"A Angel-Korman","year":"2020","unstructured":"Angel-Korman A, Jaberi A, Sanchorawala V, Havasi A. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis. Amyloid. 2020;27(1):17\u201324.","journal-title":"Amyloid"},{"issue":"1","key":"1164_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-022-02752-4","volume":"23","author":"P Zhang","year":"2022","unstructured":"Zhang P, Chen X, Zou Y, Wang W, Feng Y. Value of repeat renal biopsy in the evaluation of AL amyloidosis patients lacking renal response despite of complete hematologic remission: a case report and literature review. BMC Nephrol. 2022;23(1):127.","journal-title":"BMC Nephrol"},{"issue":"2","key":"1164_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2169\/internalmedicine.9206-17","volume":"57","author":"C Shimazaki","year":"2018","unstructured":"Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekijima Y, et al. Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan. Intern Med. 2018;57(2):181\u20137.","journal-title":"Intern Med"},{"issue":"4","key":"1164_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.14797\/mdcvj.1150","volume":"18","author":"HE Adrogue","year":"2022","unstructured":"Adrogue HE. Amyloidosis of the heart and kidney. Methodist Debakey Cardiovasc J. 2022;18(4):27\u201333.","journal-title":"Methodist Debakey Cardiovasc J"},{"issue":"36","key":"1164_CR11","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","volume":"30","author":"G Palladini","year":"2012","unstructured":"Palladini G, Dispenzieri A, Gertz MA, Kumar S, Wechalekar AD, Hawkins PN, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes. J Clin Oncol. 2012;30(36):4541\u20139.","journal-title":"J Clin Oncol"},{"key":"1164_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.3390\/hemato3020025","volume":"3","author":"R Fenoglio","year":"2022","unstructured":"Fenoglio R, Rabajoli G, Barreca A, De Simone E, Sciascia S, Roccatello D. Histological kidney re-evaluation after daratumumab monotherapy for AL amyloidosis. Hemato. 2022;3:367\u201372.","journal-title":"Hemato"},{"issue":"1","key":"1164_CR13","doi-asserted-by":"publisher","first-page":"15661","DOI":"10.1038\/s41598-017-15424-3","volume":"7","author":"E Imperlini","year":"2017","unstructured":"Imperlini E, Gnecchi M, Rognoni P, Sabid\u00f2 E, Ciuffreda MC, Palladini G, et al. Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells. Sci Rep. 2017;7(1):15661.","journal-title":"Sci Rep"},{"issue":"12","key":"1164_CR14","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1021\/acs.accounts.3c00045","volume":"56","author":"R Limbocker","year":"2023","unstructured":"Limbocker R, Cremades N, Cascella R, Tessier PM, Vendruscolo M, Chiti F. Characterization of pairs of toxic and nontoxic misfolded protein oligomers elucidates the structural determinants of oligomer toxicity in protein misfolding diseases. Acc Chem Res. 2023;56(12):1395\u2013405.","journal-title":"Acc Chem Res"},{"issue":"1","key":"1164_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa2028631","volume":"385","author":"E Kastritis","year":"2021","unstructured":"Kastritis E, Palladini G, Minnema MC, Wechalekar AD, Jaccard A, Lee HC, et al. Daratumumab-based treatment for immunoglobulin light-chain amyloidosis. N Engl J Med. 2021;385(1):46\u201358.","journal-title":"N Engl J Med"},{"issue":"12","key":"1164_CR16","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMoa1504942","volume":"373","author":"DB Richards","year":"2015","unstructured":"Richards DB, Cookson LM, Berges AC, Barton SV, Lane T, Ritter JM, et al. Therapeutic clearance of amyloid by antibodies to serum amyloid P component. N Engl J Med. 2015;373(12):1106\u201314.","journal-title":"N Engl J Med"},{"issue":"12","key":"1164_CR17","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1681\/ASN.2006050460","volume":"17","author":"LM Dember","year":"2006","unstructured":"Dember LM. Amyloidosis-associated kidney disease. J Am Soc Nephrol. 2006;17(12):3458\u201371.","journal-title":"J Am Soc Nephrol"},{"key":"1164_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105294","volume":"107","author":"ZL Li","year":"2024","unstructured":"Li ZL, Li XY, Zhou Y, Wang B, Lv LL, Liu BC. Renal tubular epithelial cells response to injury in acute kidney injury. EBioMedicine. 2024;107:105294.","journal-title":"EBioMedicine"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01164-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-026-01164-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-026-01164-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T18:02:03Z","timestamp":1784570523000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-026-01164-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1007\/s13730-026-01164-9","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"6 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was reviewed by the Ethics Committee of the National Hospital Organization Hiroshima-Nishi Medical Center, which granted a waiver of formal ethical approval for single case reports. Written informed consent for the kidney biopsy was obtained from the patient, and comprehensive consent for the secondary use of clinical data was obtained using an opt-out approach approved in advance by the Ethics Committee.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written consent to publish this information was obtained from the patient.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"122"}}